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Abstract
Purpose Odontogenic sinusitis and sinonasal complications of dental disease or treatment (SCDDT) represent a hetero-
geneous group of conditions that often require multidisciplinary care. The present study aims to prospectively validate a 
classification and treatment protocol for SCDDT patients.
Methods One hundred twenty-eight consecutive patients (73 females and 45 males, mean age 52.4 years) affected by SCDDT 
not responding to dental and medical therapy were classified and surgically treated according to the proposed protocol. The 
protocol classified patients into three aetiology-based groups (preimplantologic, implantologic, and related to traditional 
dental diseases and procedures, respectively). The groups were further divided into classes according to the presence of oro-
antral communications and/or dislocated dental hardware. Each condition was treated according to the class-related, protocol-
defined treatment, by either a transnasal or combined transnasal/transoral approach. All patients were successfully classified 
according to our protocol. None of the proposed classes were redundant, and no condition fell outside the definitions.
Results The surgical treatment protocol proved to be adequate and effective, in that 125 of the 128 patients completely 
recovered after surgical treatment.
Conclusions The term SCDDT and the consequent classification proposed by the authors appear, therefore, to be nosologi-
cally correct. Furthermore, the protocol-related proposed treatment appears to be clinically sound, with a success rate near-
ing 98%.
Keywords Sinusitis · Paranasal sinuses disease · Endoscopic sinus surgery · Computed tomography · Dental implants · 
Sinus lift
Introduction
In the 2012 European Position Paper on Rhinosinusitis [1], 
odontogenic rhinosinusitis (OS) is briefly mentioned as a 
possible cause of chronic rhinosinusitis (CRS), but only a 
limited description of OS is given. Nevertheless, there is 
some evidence of an increase of cases; some studies report 
that the odontogenic aetiology accounts for 10–30% of cases 
of maxillary rhinosinusitis [2, 3], affecting 75% of patients 
with symptomatic unilateral maxillary rhinosinusitis under-
going surgical treatment [4].
Despite frequent reports of bilateral involvement [5, 6], 
OS is usually suspected only in patients with unilateral rhi-
nosinusitis with a longstanding history of maxillary dental 
problems or a recent history of a maxillary dental procedure. 
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Moreover, odontogenic aetiology is often overlooked as a 
cause of rhinosinusitis by otolaryngologists, dentists, and 
radiologists, often due to an inadequate consensus on patho-
logical conditions to consider as being OS [7].
While OS has been traditionally related to dental condi-
tions [8], more recent views [9] have attempted to integrate 
into the definition of “sinonasal complications of dental 
disease or treatment” (SCDDT) implant-related and sinus 
augmentation-related sinonasal conditions [10, 11]. OS and 
SCDDT usually occur when Schneider’s membrane integrity 
is compromised by dental pathologies or iatrogenic causes 
[8, 12–14]. Due to the interruption of the mucoperiosteum, 
there is a higher chance of infections caused by microorgan-
isms, which often include anaerobes and occasionally unu-
sual oral species that ascend from the oral cavity [15–17].
Given the different aetiology and the frequent findings of 
retained dental metal hardware or foreign bodies, the man-
agement of these patients requires a surgeon with a proper 
training both in the area of endoscopic sinus surgery (ESS) 
and in that of oral surgery [18, 19]. Although ear, nose, and 
throat (ENT) specialists or oral/maxillofacial surgeons may 
possess all the required skills, a multidisciplinary coopera-
tion between ENT and oral/maxillofacial surgeons is advised 
to provide the best possible treatment.
The management of SCDDT poses, therefore, a sig-
nificant challenge, both from a nosological and a clinical 
point of view. In this regard, our group proposed in 2013 a 
treatment protocol based on the aetiology of the sinonasal 
involvement (a preimplantologic treatment, an implanto-
logic treatment, or a classic dental treatment or condition) 
(Table 1) [9]. The aim of the present work was to pro-
spectively validate the protocol for patients suffering from 
SCDDT who underwent ESS following the failure of anti-
biotic and focal dental treatment.
Materials and methods
This study was approved by the Institutional Review Board 
of the San Paolo Hospital, and a written informed consent 
was obtained from all patients prior to inclusion.
The study included 128 consecutive patients (73 females 
and 45 males, mean age 52.4 years) who had been diagnosed 
with SCDDT not responding to dental and medical therapy 
and who underwent ENT evaluation between January 2013 
and August 2016 in two tertiary care centres (i.e., Depart-
ment of Otolaryngology, San Paolo Hospital, Milan, Italy 
and Unit of Maxillofacial Surgery, Istituto Stomatologico 
Italiano, Milan, Italy).
The inclusion criteria were as follows: (1) diagnosis of 
SCDDT not responding to adequate focal dental treatment 
(either surgical or endodontic) and medical treatment; (2) 
the existence of ENT specialist and dentist/maxillofacial 
surgeon agreement on the odontogenic focus; and (3) the 
availability of a presurgical maxillofacial computed tomog-
raphy (CT) scan (either with or without contrast medium). 
Exclusion criteria were (1) history of CRS (with or without 
polyps) replacing dental treatment(s) and (2) sinonasal cav-
ity malignancy [5].
All patients were classified and surgically treated in 
accordance with the protocol published by our group, which 
is based on the aetiology and extent of the disease [9].
The classification and treatment protocol are reported 
in Table 1. Our classification is based on the following 
three groups: group I, preimplantological treatment; group 
II, implantological treatment; and group III, dental treat-
ment. Groups are further divided into classes according to 
the presence of oro-antral communication (OAC) and/or 
retained metal hardware (Table 1). When a patient fulfilled 
Table 1  Classification and surgical protocol
The table shows the surgical treatment protocol according to type of complication and presents the patient numerosity in the study accordingly. 
In case a patient fulfills the criteria for two or more classes, he/she is assigned to the uppermost class shown in the table (which is designed to 
have on top the most difficult-to-treat scenarios and at the bottom the most easily manageable conditions, thus defining a classification priority)
G group, C class, FESS functional endoscopic sinus surgery, OAC repair oro-antral communication repair
Group C Condition Treatment Cases
I (pre-implantological treatment complica-
tions)
1 Sinusitis following maxillary sinus lift 
with OAC
Combined: FESS + infected material 
removal + OAC repair
14
II (implantological treatment complica-
tions)
2a Peri-implant osteitis with sinusitis/subpe-
riosteal implant with sinusitis
Combined: FESS + implant 
removal + OAC repair
13
2b Implant dislocation with sinusitis and 
OAC
Combined: FESS + implant 
removal + OAC repair
3
2c Implant dislocation with sinusitis Implant removal + FESS 6
2d Implant dislocation without sinusitis Canine fossa approach/transnasal endos-
copy
3
III (“classic” dental disease and treatment 
complications)
3a Bacterial or fungal sinusitis with OAC Combined: FESS + OAC repair 31
3b Bacterial or fungal sinusitis FESS 58
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the criteria for two or more classes (e.g., a complication fol-
lowing maxillary sinus augmentation with peri-implant oste-
itis), the patient was assigned to the highest class shown in 
Table 1 (which is designed to have on top the most difficult-
to-treat scenarios and, at the bottom, the most easily man-
ageable conditions, thus defining a classification priority).
Prior to surgery, all patients underwent a combined ENT 
and oral/maxillofacial evaluation to evaluate them for signs 
and symptoms of rhinosinusitis through nasal endoscopy 
and oral examination. All patients underwent a cone beam 
CT head scan for final diagnosis and surgical planning. 
Orthopantomography and intraoral radiography scans were 
ordered in selected cases according to the dental/maxillofa-
cial surgeon’s needs.
All patients received pre- and post-surgical antibiotic 
therapy, based on oral levofloxacin 500 mg q.d., for 5 and 
10 days, respectively. Allergic patients were treated both pre-
surgery and postsurgery with oral cefuroxime axetil 500 mg 
twice daily; we preferred not to use amoxicillin/clavulanate 
because it is typically ineffective against SCDDT-causing 
bacteria [20]. The patients were then treated under general 
anaesthesia with a surgical procedure chosen according 
to the class-defined surgical protocol (i.e., either exclu-
sively transnasal or combined transoral and transnasal; see 
Table 1). According to the sinonasal involvement shown 
by the CT scan, the ESS was composed by one or more of 
the following procedures: for maxillary involvement with 
sinusitis, patients underwent total uncinectomy and wide 
middle antrostomy; for maxillary involvement without 
sinusitis, patients underwent partial inferior uncinectomy 
and mini-antrostomy, sized the smallest for allowing for 
the removal of retained implant hardware; for ethmoidal 
involvement, patients underwent radical ethmoidectomy; 
for frontal involvement, patients underwent a type I fron-
tal drainage according to the Draf classification; and, for 
sphenoidal involvement, patients underwent sphenoidotomy 
performed either through the sinus natural ostium or, in case 
of ethmoidal concurrent involvement, using a transethmoidal 
approach.
All patients performed nasal washes with saline solu-
tion and applied nasal niaouli oil for 30 days after surgery 
between three and four times per day. All patients under-
went ENT examination at 7 days, 30 days, and 60 days after 
surgery; however, in cases of persistent infection, patients 
were examined weekly and then, following complete recov-
ery, underwent the aforementioned regular ENT examina-
tion. Patients with a minimum follow-up of 6 months were 
included in the present study. Treatment success was consid-
ered achieved when the patient reported complete resolution 
of symptoms and no signs of mucosal inflammation were 
detected by nasal endoscopy in all the originally involved 
sinuses (i.e., no pus, crusting, or mucosal swelling). No 
CT scans were performed after treatment to confirm the 
endoscopy findings of successful treatment. Treatment suc-
cess rate as above-defined was evaluated for each group.
Results
All patients were successfully and classified within one of 
the protocol classes. No class resulted redundant, and at least 
three patients were assigned to each class.
The overall treatment success rate (as above-defined; self-
reported symptom resolution and endoscopically observed-
involved sinus healing) was 97.65%. One patient (class 1) 
required further antibiotic therapy, another one (class 3b) 
required a second surgical procedure after antrostomy clo-
sure, and a third patient (class 1) was lost to follow-up after 
disease recurrence. No intraoperative complications such as 
major bleeding, lamina papyracea, or orbital breaches or cer-
ebrospinal fluid leaks were reported. No anaesthesia-related 
adverse events were recorded. No patient had perioperative 
orbital complications, bleeding events, or cerebrospinal fluid 
leaks. Of the total patient population, 7.81% were dismissed 
on the same day of surgery, 85.93% were discharged the day 
after, and the remaining 6.25% were dismissed after two 
nights in the hospital, respectively.
In regard to patient presentation, the clinical scenario and 
extent of sinonasal involvement was the following (Table 2). 
“Classic” dental treatments and conditions (i.e., those not 
related to implantology or pre-implantologic procedures; 
group 3) were the most common cause of SCDDT, found 
in 89 patients. Additionally, 31/89 (34.8%) patients with 
SCDDT not related to implantological or preimplantological 
procedures associated with an OAC (class 3a); 5/89 (5.6%) 
had unilateral maxillary involvement; 25/89 patients (28.1%) 
had unilateral extramaxillary involvement; and 1/89 (1.1%) 
had bilateral involvement. Of the study participants, 58/89 
(15.7%) patients demonstrated OS without OAC (class 3b), 
while 14/89 (15.7%) had unilateral maxillary involvement, 
37/89 (41.6%) had unilateral extramaxillary involvement, 
and 7/89 (7.9%) had bilateral involvement. None of these 
patients had peri-implant osteitis or retained implant hard-
ware. Patients treated for implantologic surgery complica-
tion (group 2) were 25 in number; of these, 9/25 (36.0%) 
had unilateral maxillary involvement and 16/25 (64.0%) 
had unilateral extramaxillary rhinosinusitis. Additionally, 
among these 25 patients, 13/25 (52%) had peri-implant 
osteitis without implant dislocation (class 2a), 3/25 (12%) 
had an OAC with implant dislocation (class 2b), 6/25 (24%) 
had an implant dislocation with sinusitis, and 3/25 (12%) 
an implant dislocation without sinusitis. Fourteen patients 
who underwent surgery for preimplantological complication 
(group 1); 12/14 (85.7%) of them had unilateral extramax-
illary involvement, 1/14 (7.1%) had unilateral maxillary 
involvement, and 1/14 (7.1%) had bilateral involvement. 
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None of these patients had peri-implant osteitis or retained 
metal implant hardware. Table 2 provides a brief overview 
of these reported results.
During the surgical procedure, 54/128 patients were 
recorded as showing signs of ostio-meatal complex obstruc-
tion. Six of them showed signs of inflammatory degeneration 
of the mucosa of the ethmoid and/or ostio-meatal complex, 
while the remaining 48 had anatomic anomalies such as 
septal deviation, massive inferior turbinates hypertrophy, or 
middle turbinate concha bullosa, which possibly pre-existed 
the SCDDT.
Discussion
Often overlooked as a cause of sinonasal disease by otolar-
yngologists, dentists, and radiologists, OS deserves special 
consideration because it differs in terms of its microbiol-
ogy; pathophysiology; and, consequently, management in 
comparison with “rhinogenic” sinonasal disease [21]. As 
reported by Albu and Baciut [22], the majority of rhinosi-
nusitis guidelines written in the last decade do not include 
OS as a cause of CRS. OS is infrequently mentioned in the 
most recent guidelines and the literature lacks coverage of 
standard protocols regarding its diagnosis and management 
[23].
In 2013, our group proposed the new concept of SCDDT 
and a new classification system and subsequently focused on 
establishing a treatment protocol [9]. The protocol introduces 
the need for combining ESS and intraoral approaches for 
some specific aetiopathogenetic cases, such as graft dis-
placement after sinus augmentation, sinonasal foreign bod-
ies (e.g., implants, teeth, dental tools), and oro-antral com-
munications. This protocol was introduced prospectively in 
our daily SCDDT treatment practice guidelines. Surgery 
proved to be adequate and effective, as 97.7% of patients 
completely recovered, in contrast with other studies where 
the disease recurred with consequent need for redo surgery 
in 9–14% of patients [24]. However, one of the weak points 
of our protocol is the administration of pre- and post-opera-
tive antibiotic therapy, which is not supported by guidelines 
or any other evidence besides our daily practice. Therefore, 
the choice to perform such antibiotic therapy in our case 
series might lead to some bias in interpreting our positive 
results, and this has to be taken into account. The rationale 
of the antibiotic therapy of choice for this paper lies in our 
previous case series [9], where we noted that most treatment 
failures in the patient cohort occurred in those who did not 
receive quinolone therapy. Further insight into the postop-
erative therapy of SCDDT patients is definitely required and 
only the publication of other large case series could enable 
to production of strong guidelines.
The results obtained by authors who have already intro-
duced our protocol into their daily practice seem to be in line 
with the findings of our reports. More specifically, Fadda 
et al. applied the same protocol to 31 patients and all of them 
demonstrated improvements in rhinosinusitis symptoms as 
confirmed by clinical examination and CT scan; additionally, 
Table 2  Patient classification and clinical results
The table shows the case series composition, according to the SCDDT classification along with the degree of sinonasal involvement. All rates 
are calculated among homogeneous classes and groups. Numbers in brackets indicate patients who failed after the first surgical treatment










n Rate (%) n Rate (%) n Rate (%)
Total SCDDT patients 29 22.7 90 70.3 9 7.0 128
Groups
 I Preimplantologic surgery complication 1 7.1 12 85.7 1 7.1 14
 II Implantologic surgery complication 9 36.0 16 64.0 0 0.0 25
 III “Classic” dental treatment complication 19 21.3 62 69.7 8 9.0 89
Classes
 1 Sinusitis following preimplantologic surgery 1 7.1 12 (1) 85.7 1 7.1 14
 2a Sinusitis with perimplantitis/subperiosteal implant and OAC 3 23.1 10 76.9 0 0.0 13
 2b Sinusitis following implant dislocation with OAC 1 33.3 2 66.7 0 0.0 3
 2c Sinusitis following implant dislocation 2 33.3 4 66.7 0 0.0 6
 2d Implant dislocation 3 100.0 0 0.0 0 0.0 3
 3a Odontogenic sinusitis with OAC 5 16.1 25 (1) 80.6 1 3.2 31
 3b Odontogenic sinusitis 14 24.1 37 (1) 63.8 7 12.1 58
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no significant complications were recorded and no instance 
of revision surgery was required [12].
From our standpoint, the need for a different protocol for 
OS patients comes naturally if we consider that this group 
of conditions requires unique diagnostic criteria and a treat-
ment regimen that differs from nonodontogenic rhinosi-
nusitis. Surgical planning for OS patients requires the spe-
cific evaluation of the aetiology and the extent of sinonasal 
involvement. Radiological imaging is an important tool for 
establishing a diagnosis and includes periapical radiogra-
phy, panoramic radiography, and CT, with the latter being 
considered the gold standard for diagnosing odontogenic 
rhinosinusitis [25]. In a series of 55 patients with OS, Wang 
et al. [26] noticed that only 65% of radiology reports men-
tioned dental pathology, and 20% of these patients were only 
diagnosed after a retrospective analysis of the presentation 
and outcomes. Another study from our group [5] showed 
that only 40% of patients had a condition limited to the max-
illary sinus, while the remaining percentage demonstrated 
a more extensive sinonasal involvement. For this reason, 
OS treatment should focus not only on the maxillary sinus 
but also on all sinonasal cavities involved (i.e., where CT 
scans show sinus opacation or any kind of foreign body), 
as already detailed in the “Materials and methods” section, 
to minimize the number of recurrences. Imaging has also 
maintained the pivotal role of differentiating rhinosinusi-
tis caused by obstructed drainage pathways and that caused 
by odontogenetic disease. Failure to identify the dental or 
obstructive origin of a sinusitis can lead to the misdiagnosis 
of an SCDDT case as an instance of CRS. As already stated, 
SCDDT/OS and CRS are different entities in terms of aetiol-
ogy, pathophysiology, and management [27].
There are indeed some previous studies in existence that 
attempted to categorize the dental aetiologic factors of rhi-
nosinusitis according to their frequency and importance; 
however, they mostly showed a lack of internal and external 
consistency, suggesting that different (and often variable) 
dental etiologic factors be included and proposing various 
methods of diagnosing and managing cases of rhinosinusitis 
that had dental sources [28]. Multiple studies have shown 
excellent results with ESS and dental surgery, although the 
ideal sequence of management is not clear [29]. Wang et al. 
[26] presented a 55 OS patient case series, whose diagno-
sis and treatment schedule did not appear very clear. Other 
studies in the literature show favourable results, recommend-
ing dental surgery as a core component of management, but 
they often propose different treatment protocols for the same 
pathology [30], Astonishingly, in the era where ESS is rec-
ognized as the surgical treatment of choice for chronic rhi-
nosinusitis, the classic Caldwell–Luc approach is still sug-
gested by some authors [31] despite its significant morbidity. 
In the event that an intraoral approach to the sinus (e.g., for 
removing grafts) is needed, we tend to prefer less invasive 
approaches, such as the antral retriever [32] or the creation 
of a bony window pedicled to Schneider’s membrane [33].
Last, but definitely not least, the close collaboration 
among maxillofacial/oral surgeons, implantologists, and 
ENT specialists is pivotal to correctly diagnose and treat 
complex cases of SCDDT. Multidisciplinary treatment 
allows for the achievement of a rapid recovery and a mini-
mization of the risk of recurrence. This is especially true for 
group I complications, a condition in which the presence of 
grafts and the systematic manipulation of the Schneiderian 
membrane during the augmentation procedure exposes the 
maxillary sinus to higher risks when compared with other 
dental procedures [34, 35].
Conclusion
In 2013, the authors moved away from the concept of OS, 
by introducing the definition of SCDDT. This change is not 
merely dictated by a taxonomic need, since prior dental 
treatments have almost invariably to be considered the pri-
mum movens in this type of conditions. The results herein 
reported show that the protocol we proposed is outcome-ori-
ented, safe, and effective, with a success rate of nearly 98%. 
In view of this favourable outcome, we hope that diffusion 
of the protocol might contribute to a better understanding of 
the key clinical characteristics of SCDDT, improved physi-
cian awareness and management choices, and comparison 
of treatment results among different groups.
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